Cargando…
Cross-reactive antibodies after SARS-CoV-2 infection and vaccination
Current SARS-CoV-2 vaccines are losing efficacy against emerging variants and may not protect against future novel coronavirus outbreaks, emphasizing the need for more broadly protective vaccines. To inform the development of a pan-coronavirus vaccine, we investigated the presence and specificity of...
Autores principales: | Grobben, Marloes, van der Straten, Karlijn, Brouwer, Philip JM, Brinkkemper, Mitch, Maisonnasse, Pauline, Dereuddre-Bosquet, Nathalie, Appelman, Brent, Lavell, AH Ayesha, van Vught, Lonneke A, Burger, Judith A, Poniman, Meliawati, Oomen, Melissa, Eggink, Dirk, Bijl, Tom PL, van Willigen, Hugo DG, Wynberg, Elke, Verkaik, Bas J, Figaroa, Orlane JA, de Vries, Peter J, Boertien, Tessel M, Bomers, Marije K, Sikkens, Jonne J, Le Grand, Roger, de Jong, Menno D, Prins, Maria, Chung, Amy W, de Bree, Godelieve J, Sanders, Rogier W, van Gils, Marit J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610423/ https://www.ncbi.nlm.nih.gov/pubmed/34812143 http://dx.doi.org/10.7554/eLife.70330 |
Ejemplares similares
-
Antibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines in health care workers in the Netherlands: A prospective cohort study
por: van Gils, Marit J., et al.
Publicado: (2022) -
Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccination
por: Caniels, Tom G., et al.
Publicado: (2021) -
Antigenic cartography using sera from sequence-confirmed SARS-CoV-2 variants of concern infections reveals antigenic divergence of Omicron
por: van der Straten, Karlijn, et al.
Publicado: (2022) -
A single mRNA vaccine dose in COVID-19 patients boosts neutralizing antibodies against SARS-CoV-2 and variants of concern
por: van Gils, Marit J., et al.
Publicado: (2021) -
Time since SARS-CoV-2 infection and humoral immune response following BNT162b2 mRNA vaccination
por: Appelman, Brent, et al.
Publicado: (2021)